Table 3 Probability of heart stress in the study population
Univariate analysis | Multivariate analysis* | |||
|---|---|---|---|---|
OR (95% CI) | p | OR (95% CI) | p | |
Age (years) | 1.1 (1.0–1.1) | < 0.001 | – | – |
CKD (eGFR < 60 ml/min/1.73m2) | 3.5 (1.6–7.4) | 0.001 | 2.8 (1.3–6.2) | 0.012 |
eGFR (ml/min/1.73m2) | 0.9 (0.9–1.0) | 0.002 | – | – |
Ln(Tryglicerides) | 0.3 (0.1–0.7) | 0.006 | – | – |
Metformin | 0.3 (0.2–0.6) | 0.001 | – | – |
MRA | 3.2 (0.9–11.1) | 0.051 | – | – |
Beta-blocker | 2.4 (1.2–4.5) | 0.009 | – | – |
Alpha-blocker | 5.2 (1.6–16.2) | 0.005 | – | – |
Number of anti-hypertensives | 1.8 (1.3–2.3) | < 0.001 | 1.8 (1.3–2.5) | 0.001 |